David Howard

4.3k total citations
68 papers, 2.8k citations indexed

About

David Howard is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, David Howard has authored 68 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 25 papers in Pulmonary and Respiratory Medicine and 16 papers in Rheumatology. Recurrent topics in David Howard's work include Head and Neck Surgical Oncology (19 papers), Tracheal and airway disorders (15 papers) and Bone Tumor Diagnosis and Treatments (11 papers). David Howard is often cited by papers focused on Head and Neck Surgical Oncology (19 papers), Tracheal and airway disorders (15 papers) and Bone Tumor Diagnosis and Treatments (11 papers). David Howard collaborates with scholars based in United Kingdom, United States and Hong Kong. David Howard's co-authors include Valerie J. Lund, WI Wei, Glyn Lloyd, Anthony D. Cheesman, Peter Phelps, Laura Briggs, Margaret F Spittle, Chris A. Pritsos, David Gelmont and Michael Unger and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

David Howard

67 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Howard United Kingdom 31 1.5k 966 572 465 454 68 2.8k
Henrik Hellquist Sweden 30 1.3k 0.8× 371 0.4× 255 0.4× 660 1.4× 529 1.2× 113 2.8k
Patrizia Morbini Italy 34 1.0k 0.7× 1.0k 1.0× 196 0.3× 211 0.5× 67 0.1× 155 3.8k
Petra Ambrosch Germany 30 1.4k 0.9× 1.4k 1.4× 387 0.7× 1.9k 4.2× 74 0.2× 99 3.4k
George Gallagher United States 26 621 0.4× 277 0.3× 371 0.6× 128 0.3× 253 0.6× 78 2.0k
Jean-Michel Vignaud France 32 526 0.3× 909 0.9× 162 0.3× 174 0.4× 95 0.2× 87 2.9k
Giovanni Almadori Italy 35 1.2k 0.8× 930 1.0× 115 0.2× 1.3k 2.8× 77 0.2× 149 3.5k
Dian Wang United States 30 762 0.5× 1.5k 1.5× 415 0.7× 504 1.1× 53 0.1× 156 3.6k
Harlan J. Spjut United States 35 1.0k 0.7× 1.6k 1.7× 931 1.6× 55 0.1× 330 0.7× 98 3.4k
Theodore F. Beals United States 26 384 0.2× 195 0.2× 390 0.7× 110 0.2× 61 0.1× 52 2.0k
Cheng‐Ping Wang Taiwan 31 1.2k 0.8× 722 0.7× 183 0.3× 1.0k 2.2× 152 0.3× 163 3.1k

Countries citing papers authored by David Howard

Since Specialization
Citations

This map shows the geographic impact of David Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Howard more than expected).

Fields of papers citing papers by David Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Howard. The network helps show where David Howard may publish in the future.

Co-authorship network of co-authors of David Howard

This figure shows the co-authorship network connecting the top 25 collaborators of David Howard. A scholar is included among the top collaborators of David Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Howard. David Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powell, Lydia C., David W. James, David Howard, et al.. (2025). Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasion. Frontiers in Cell and Developmental Biology. 13. 1450407–1450407. 1 indexed citations
2.
Howard, David, David H. James, Jetzabel García-Parra, et al.. (2022). Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer. Frontiers in Oncology. 12. 1014280–1014280. 10 indexed citations
3.
Howard, David, David H. James, Kate Murphy, et al.. (2021). Dinaciclib, a Bimodal Agent Effective against Endometrial Cancer. Cancers. 13(5). 1135–1135. 10 indexed citations
4.
Howard, David, Jetzabel García-Parra, Gareth D. Healey, et al.. (2016). Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. Interface Focus. 6(6). 20160054–20160054. 16 indexed citations
5.
Rimmer, Joanne, Valerie J. Lund, Timothy Beale, WI Wei, & David Howard. (2013). Olfactory neuroblastoma: A 35‐year experience and suggested follow‐up protocol. The Laryngoscope. 124(7). 1542–1549. 85 indexed citations
6.
Nouraei, S.A.R., Premjit S. Randhawa, Colin R. Butler, et al.. (2009). Validation of the Clinical COPD Questionnaire as a psychophysical outcome measure in adult laryngotracheal stenosis. Clinical Otolaryngology. 34(4). 343–348. 23 indexed citations
7.
Nouraei, S.A.R., et al.. (2008). Sensitivity and responsiveness of the medical research council dyspnoea scale to the presence and treatment of adult laryngotracheal stenosis. Clinical Otolaryngology. 33(6). 575–580. 28 indexed citations
8.
Nouraei, S.A.R., Ann Sandison, David Howard, & Guri Sandhu. (2008). The Prefabricated Sternohyoid Myocartilagenous Flap: A Reconstructive Option for Treating Recalcitrant Adult Laryngotracheal Stenosis. The Laryngoscope. 118(4). 687–691. 2 indexed citations
9.
Nouraei, S.A.R., et al.. (2007). Outcome of Endoscopic Treatment of Adult Postintubation Tracheal Stenosis. The Laryngoscope. 117(6). 1073–1079. 50 indexed citations
10.
Hassan, Mohammed, Valerie J. Lund, David Howard, & Amanda Sacker. (2006). Are the demographics for squamous cell cancer in the head and neck changing in the United Kingdom?. The Journal of Laryngology & Otology. 121(2). 154–157. 5 indexed citations
11.
Howard, David, Valerie J. Lund, & WI Wei. (2006). Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: A 25-year experience. Head & Neck. 28(10). 867–873. 128 indexed citations
12.
Lim, Ming Yann, et al.. (2006). Whitehead's varnish nasal pack. The Journal of Laryngology & Otology. 121(6). 592–594. 7 indexed citations
13.
Lund, Valerie J., David Howard, WI Wei, & Margaret F Spittle. (2003). Olfactory Neuroblastoma: Past, Present, and Future?. The Laryngoscope. 113(3). 502–507. 155 indexed citations
14.
Howard, David, Glyn Lloyd, & Valerie J. Lund. (2001). Recurrence and Its Avoidance in Juvenile Angiofibroma. The Laryngoscope. 111(9). 1509–1511. 99 indexed citations
15.
Lloyd, Guy, Valerie J. Lund, David Howard, & Lloyd Savy. (2000). Optimum imaging for sinonasal malignancy. The Journal of Laryngology & Otology. 114(7). 557–562. 54 indexed citations
16.
Lund, Valerie J., et al.. (1999). Management Options and Survival in Malignant Melanoma of the Sinonasal Mucosa. The Laryngoscope. 109(2). 208–211. 138 indexed citations
17.
Bottrill, Ian, Simon Wood, Peter Barrett‐Lee, & David Howard. (1994). Mesenchymal chondrosarcoma of the maxilla. The Journal of Laryngology & Otology. 108(9). 785–787. 11 indexed citations
18.
Howard, David & Valerie J. Lund. (1992). The midfacial degloving approach to sinonasal disease. The Journal of Laryngology & Otology. 106(12). 1059–1062. 34 indexed citations
19.
Lund, Valerie J. & David Howard. (1990). Head and neck cancer in the young: A prognostic conundrum?. The Journal of Laryngology & Otology. 104(7). 544–548. 37 indexed citations
20.
McCombe, Andrew, Valerie J. Lund, & David Howard. (1989). Multiple synchronous carcinoma of the aero-digestive tract. The Journal of Laryngology & Otology. 103(8). 794–795. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026